London Psychologist Gave Patients Ketamine, Now Loses License, Here's What We Know So Far

Tatiana Zdyb admitted to multiple professional misconduct charges, including intimate relationship with patient and misuse of psychedelic therapyA London-based psychologist who offered ketamine-assisted psychotherapy to clients has been stripped of her license after admitting to serious professional misconduct, including sexual abuse of a patient, misrepresenting her credentials, and offering unproven treatments.Zdyb, once publicly known for pioneering the use of psychedelic-assisted therapy in Southwestern Ontario, faced a disciplinary hearing on Wednesday before the Ontario College of Psychologists and Behaviour Analysts. The hearing addressed three separate notices of professional misconduct, culminating in the revocation of her license to practice.The hearing, held in Toronto, heard that Zdyb engaged in an inappropriate and intimate relationship with a long-time patient, provided services unlikely to benefit clients, and misrepresented both her role and the safety of the treatments she was offering.“These findings are not minor breaches,” said hearing chair Ian Nicholson. “They go to the core of your responsibilities as a regulated professional… Your actions represented a fundamental and egregious betrayal of that trust.”The Psychedelic Controversy: What Is Ketamine Therapy?Ketamine, originally developed as a fast-acting anesthetic for medical and veterinary use, has in recent years found a foothold in mental health care, particularly for patients with treatment-resistant depression. It is a controlled substance in Canada, meaning its use outside regulated medical or scientific settings is illegal.When used under medical supervision, low-dose ketamine infusions or lozenges are believed to rapidly relieve depressive symptoms, sometimes within hours. However, the drug also has hallucinogenic effects and potential for misuse, raising concerns among medical professionals and regulators alike.While Zdyb was not a medical doctor, she collaborated with prescribing physicians to incorporate ketamine into her psychotherapy sessions. She had previously promoted her clinic, under names like the MindSetting Institute and Zdyb Centre for Health Promotion, as one of the first in the region to offer this form of therapy.ALSO READ: Matthew Perry Investigation: Can Ketamine Kill Someone?Ketamine is an anaesthetic used to treat depression, anxiety and pain under supervised and controlled medical settings. However, it does have its side effects, which can lead to distortion of sight, sound and time. It can also produce calming and relaxing effects.Ketamine increases a person’s heart rate and blood pressure. If overdosed, it can leave users confused and agitated and can cause them to hurt themselves without even realizing it. It can also lead to liver damage and bladder problems.However, when used in moderation and under the supervision of medical doctors, it can treat depression where traditional antidepressants have failed.Prof Rupert McShane, a University of Oxford psychiatrist who runs an NHS ketamine treatment clinic told BBC that ketamine “probably turns off the area of the brain that is involved in disappointment.”In simple terms, it cannot, be if the dosage is given in a controlled setting and as prescribed. Ketamine infusion therapy uses drugs in small doses than those used for anaesthesia. It acts faster than traditional anti-depressants, but the effects also wear off way quickly. Which is why it is important to monitor patients’ mental state for relapsing back into depression and discouraging them from overdosing on it.YOU MAY WANT TO READ: Can You Use Ketamine To Treat Depression?Disciplinary Action Follows Settled LawsuitThe College first issued an interim suspension of Zdyb’s licence in August 2023, pending investigation. But the roots of concern stretch back even further. Lawyer John Nicholson, who represented a former client of Zdyb's under the pseudonym “A.A.”, said his client’s mental health significantly deteriorated after receiving ketamine treatment under Zdyb’s care in 2020 for mild depression.“She got worse,” Nicholson told CBC News. “And later, Zdyb recommended psilocybin [magic mushrooms] without having the training or expertise to manage that process. My client was unable to return to work and suffered greatly.”The lawsuit alleged not only inappropriate treatment but also that Zdyb entered into a romantic relationship with A.A. during the course of her therapy, a clear violation of regulatory rules that prohibit any sexual relationship for at least one year after treatment ends. The case was settled out of court, with Nicholson confirming a monetary agreement but declining to share further details.Admitted Misconduct and License RevocationAt Wednesday’s hearing, Zdyb admitted to all the allegations presented. Her legal representative, Grant Ferguson, acknowledged the “most serious” charge was the sexual relationship with a former client, which began in September 2022, the same month the patient ceased treatment.But the College’s regulations are unequivocal: any romantic involvement within a year of therapy ending constitutes sexual abuse, carrying severe consequences including mandatory licence revocation.

London Psychologist Gave Patients Ketamine, Now Loses License, Here's What We Know So Far

Quick Stories

Your Home May Look Clean, But These 8 Spots Are Dirtier Than You Think

Did You Know? You're Wired To Monotask, Not Multitask

4 Rare Heart Diseases That Are Becoming Common By Each Passing Day

Health Conditions A-Z

Your Home May Look Clean, But These 8 Spots Are Dirtier Than You Think

Did You Know? You're Wired To Monotask, Not Multitask

Legionnaires Outbreak: All That You Need To Know About The Disease That Killed 1 And Left 22 Sick In New York